Geneos Wealth Management’s ArcBest ARCB Stock Holding History

Geneos Wealth Management’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$1K	–	2514
2025 Q2	$1K	Sell	13 -26	-67%	-$1.69K	﹤0.01%	2982
2025 Q1	$2.75K	Buy	39 +26	+200%	+$2.25K	﹤0.01%	2911
2024 Q4	$1.21K	Hold	13	–	–	﹤0.01%	2729
2024 Q3	$1.41K	Buy	+13	New	+$1.43K	﹤0.01%	2374
2023 Q1	–	Sell	-88	Closed	-$6.16K	–	2045
2022 Q4	$6.16K	Buy	+88	New	+$6.79K	﹤0.01%	1658
2017 Q1	–	Sell	-1,700	Closed	-$47K	–	2061
2016 Q4	$47K	Hold	1,700	–	–	0.01%	860
2016 Q3	$32K	Hold	1,700	–	–	﹤0.01%	957
2016 Q2	$28K	Hold	1,700	–	–	﹤0.01%	1003
2016 Q1	$35K	Buy	+1,700	New	+$34.6K	0.01%	909

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's ARCB Position: Q3 2025 in Review

Geneos Wealth Management sold out of ArcBest (ARCB) in Q3 2025, closing a stake of 13 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in ARCB in Q1 2016 and held it in 9 quarters. The position peaked at $47K in Q4 2016. 270 funds tracked by Wall St. Rank hold ARCB as of Q3 2025.

Geneos Wealth Management reported no remaining ArcBest position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 13 ArcBest shares in Q3 2025, an estimated $1K.
Geneos Wealth Management first reported a position in ArcBest in Q1 2016 and held it in 9 quarters.
Geneos Wealth Management's ArcBest position peaked at $47K in Q4 2016.
270 funds tracked by Wall St. Rank held ArcBest as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.